Doctors

Lisa N. Abaid, MD

Lisa N. Abaid, MD, MPH, FACOG, FACS, completed her undergraduate study at Auburn University. She attended Medical School at the University of Miami. Dr Abaid performed her Residency in Gynecology and Obstetrics at the University of North Carolina at Chapel Hill. Her Fellowship sub-specialization in Gynecologic Oncology was also completed at the University of North Carolina.

BUSINESS ADDRESS
Gynecologic Oncology Associates
351 Hospital Road
Suite 507 Newport Beach, CA 92663
Phone: (949) 642 1361
Fax: (949) 642 1394

EDUCATION AND TRAINING
7/2005 – 6/2008 University of North Carolina at Chapel Hill Clinical Fellow, Division of Gynecologic Oncology
2005 – 2006 University of North Carolina at Chapel Hill Master of Public Health, Health Policy and Administration
2003 – 2004 Administrative Chief Resident, Obstetrics and Gynecology
2000 – 2004 University of North Carolina at Chapel Hill Resident, Obstetrics and Gynecology
1996 – 2000 University of Miami School of Medicine, Miami, Florida Doctor of Medicine
1992 – 1996 Auburn University, Auburn AL Bachelor of Science, Biomedical Sciences, Summa Cum Laude

PROFESSIONAL EXPERIENCE
2004 – 2005 University of North Carolina at Chapel Hill Clinical Assistant Professor, Obstetrics and Gynecology

LICENSURE
2008 California Medical License #A104885
2005 American Board of Obstetrics and Gynecology
2003 North Carolina Medical License #2003-01434
2003 National Board of Medical Examiners

HONORS AND AWARDS

American Association of Gynecologic Laparoscopy
Center of Excellence in Minimally Invasive Gynecologic Surgery
Surgeon Designee

University of North Carolina at Chapel Hill Golden Tarheel Teaching Award

University of North Carolina at Chapel Hill Ob/Gyn Resident Teacher of the Year

Wake Medical Center/Wake Area Health Education Concern Ob/Gyn Resident Teacher of the Year

2001 University of North Carolina at Chapel Hill Kaiser Permanente Excellence in Teaching Award for Residents

University of Miami School of Medicine Medical Alumni Scholarship for Academic Excellence

1992 – 1996 Auburn University Full tuition academic scholarship

1994 Auburn University Phi Kappa Phi National Honor Society

RESEARCH
Funded Research:
Correlation between amount of smoking and severity of cervical dysplasia 07/04 – 07/05 ACOG/Cytyc Research Award for Cervical Cancer Screening ($15,000)

Principal Investigator A cross-sectional study to determine the association between smoking frequency and intensity with cotinine and nicotine levels in the urine and cervical mucus, and to correlate these levels with dysplasia severity
at time of presentation.

Ongoing Research:
07/05 – 07/08
Division of Gynecologic Oncology, Chapel Hill, NC Principal Investigator A review of all patients with uterine sarcoma treated at UNC Chapel Hill during the years 1980-2005. Specific research aims include to describe patterns of recurrence and to determine the impact of adjuvant radiation on disease-free and overall survival.

Peer Reviewed Publications:

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience. Surg Oncol 2016; 25: 66-71.

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A randomized, controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancer. Int J Gynecol Cancer 2016; 26:389-393.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Lopez KL, Goldstein BH. Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. Int J Surg 2015; 19:27-30.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH.
The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma.
Arch Gynecol Obstet 2015; 291:1381-6.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients. JSLS 2015;19: 1-5.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Hyperthermia 2015;31:8-14.

Brown JV, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. The Safety and Feasibility of Robotic Lymph Node Staging in Early-Stage Ovarian Cancer. Int J Gynecol Cancer 24(8) 2014.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP, Goldstein BH. The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study. Int J Surg 2014; 12: 783-787.

Rettenmaier CR, Rettenmaier NB, Abaid LN, Brown JV, Micha JP, Mendivil AA, Wojciechowski T, Goldstein BH, Markman M. The Incidence of Genitourinary and Gastrointestinal Complications in Open and Endoscopic Gynecologic Cancer Surgery. Oncology 2014; 86:303-307

Mendivil AA, Brown III JV, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. Robotic-Assisted Surgery for the Treatment of Pelvic Masses in Pregnant Patients: A Series of Four Cases and Literature Review.J Robot Surg 2013; 7: 333–337. Care 2013; 2: 124.

Rettenmaier MA, Khan HJ, Epstein HD, Nguyen D, Abaid LN, Goldstein BH. Gestational Choriocarcinoma in the Fallopian Tube. J Obstet Gynaecol 2013; 912-914

Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother Pharmacol 2013;72:101-107.

Micha JP, Brown JV, Rettenmaier MA, Abaid LN, Mendivil AA, Lopez KI, Goldstein BH. Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian cancer. Clin Oncol 2013; Feb (letter).

Mendivil AA, Micha JP, Brown JV 3rd, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH. Increased incidence of severe gastrointestinal events with first-line Paclitaxel, Carboplatin, and Vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. Int J Gynecol Cancer 2013;23:533-9.Abaid LN,

Cupp JS, Brown JV, Goldstein BH. Primary Small Cell Neuroendocrine Carcinoma of the Endometrium. Oncol 2012; 5:439–443.

Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV 3rd, Micha JP, Wabe MA, Goldstein BH. Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 2012; 17:569-74.

Rettenmaier MA, Mendivil AA, Brown JV III, Abaid LN, Micha JP, Goldstein BH. Same Day Discharge in Clinical Stage 1 Endometrial Cancer Patients Treated with Total Laparoscopic Hysterectomy, Bilateral Salpingoophorectomy and Bilateral Pelvic Lymphadenectomy. Oncol 2012;82:321-326

Clarke-Pearson DL, Abaid LN. Prevention of venous thromboembolic events after gynecologic surgery. Obstet Gynecol. 2012 Jan;119(1):155-67.

Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer.  J Gynecol Oncol 2012; 23: 22-27.

Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.

Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2012; 17:569-74.

Abaid LN, Goldstein BH, Lopez KL, Micha JP, Brown JV, Rettenmaier MA, Markman M. The Prognostic Significance of Optimal Debulking in the Setting of a Complete Clinical Response for Advanced Ovarian Carcinoma Patients Receiving Maintenance Chemotherapy. Arch Gynecol Obstet 2011; 283: 1127-1131.

Rettenmaier Epstein HD, Abaid L, Bechtol KA, Goldstein BH. Leiomyosarcoma with Synchronous Clear Cell Ovarian Carcinoma. Onkologie 2010;33(12):695-697. Epub 2010 Nov 26M,

Abaid LN, Goldstein BH, Lopez KL, Micha JP, Brown JV, Rettenmaier MA, Markman M. The prognostic significance of optimal debulking in the setting of a complete clinical response for advanced ovarian carcinoma patients receiving maintenance chemotherapy. Accepted to Arch Gynecol Obstet 2010.

Abaid LN, Goldstein BH, Micha JP, Rettenmaier MA, Brown JV, Markman M. Improved overall survival with 12 cycles of single agent paclitaxel maintenance therapy following a complete response to induction chemotherapy in advanced ovarian carcinoma. Accepted to Oncol 2010.

Brown JV III, Micha JP, Rettenmaier MA, Abaid LN, Lopez K, Goldstein BH. A pilot study evaluating a novel regimen comprised of carboplatin, paclitaxel, and bevacizumab for advanced stage ovarian carcinoma. Accepted to Int J Gynecol Cancer 2010.

Abaid LN, Lopez K, Micha JP, Rettenmaier MA, Brown JV, Goldstein BH. An absence of bowel perforations with bevacizumab in the treatment of advanced stage ovarian carcinoma. Euro J Gynaecol Oncol 2010; 3: 308-311 .

Rettenmaier MA, Abaid LN, Brown JV, Micha JP, Goldstein BH. Chemotherapy and patient co-morbidity in ventral site hernia development. J Gynecol Oncol 2009;20:246-50.

Rettenmaier MA, Lopez K, Abaid LN, Brown JV, Micha JP, Goldstein BH. Borderline Ovarian Tumors and Extended Patient Follow-up: An Individual Institution’s Experience. J Surg Oncol 2009; 101:18-21.

Abaid LN, Epstein HD, Chang M, Kankus R, Goldstein BH. Endometrial Adenocarcinoma with Concomitant Left Atrial Myxoma. Case Rep Oncol 2009;2 :150-156

Rettenmaier MA, Abaid LN, Erwin MR, John CR, Micha JP, Brown JV 3rd, Goldstein BH. A Retrospective Review of the GelPort System in Single-Port Access Pelvic Surgery. J Minim Invasive Gynecol 2009; 16:743-7.

Zekry N, Rettenmaier MA, Abaid LN, John CR, Micha JP, Brown JV, Goldstein BH. Perivascular Epithelioid Cell Neoplasms: A Systematic Review of Prognostic Factors. J Minim Invasive Gynecol 2009; 16:527-32.

Milam MR, Abaid L, dos Reis R, Frumovitz M, Gehrig PA, Livasy C, Broaddus RR, Ramirez PT. Microscopic Evaluation of Lymph Node-Bearing Tissue in Early Stage Cervical Cancer: A Dual Institution Review. Annals of Surgical Oncology, in press

Rettenmaier CR, Abaid LN, Hu JC, Brown JV 3rd , Micha JP, Goldstein BH. Delayed staple erosion into the bladder after removal of a benign ovarian mass. J Minim Invasive Gynecol 2009; 16:491-2.

Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Gynecologic
Oncology, 2008 Aug 9.

Moore KN, Moxley KM, Fader AN, Axtell AE, Rocconi RP, Abaid LN, Cass IA, Rose PG, Leath CA, Rutledge T, Blankenship D, Gold MA. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control
comparison to serous adenocarcinoma of the ovary. Gynecologic Oncology. 2007 Dec;107(3):398-403.

Abaid LN, Grimes DA, Schulz KF. Reducing publication bias through trial registration. Obstetrics and Gynecology. 2007 June; 109(6):1434-7.

Abaid LN, As-Sanie S, Wolfe H. Relationship between crown-rump length and early detection of cardiac activity. J Reprod Med. 2007 May; 52(5):375-8.

Rettenmaier NB, Rettenmaier CR,Wojciechowski T,Abaid LN, Brown JV 3rd, Micha JP, Goldstein BH. The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review.  Br J Cancer 2010;103:1657-62.

Non-Peer Reviewed Publications:
Clarke-Pearson DL, Abaid LN, Cantrell L, Shafer A. ACOG Monograph: Clinical Updates in Women’s Health Care – Perioperative Considerations in Women with Coexisting Medical Conditions. In press.

Clarke-Pearson DL, Abaid LN. Prevention of Deep Vein Thrombosis and Pulmonary Embolism. ACOG Practice Bulletin Number 84: Gynecology. August 2007.

Abaid LN, Boggess JF. Current Applications of Laparoscopy in Gynecologic Oncology: A Literature Review. The Women’s Oncology Review. December 2005;5(4):193-201.

Book Chapters:

Clarke-Pearson DL, Ko E, Abaid LN, Schuler K. Preoperative Evaluation and Postoperative Management. In: Berek & Novak’s Gynecology, 15th Ed. Edited by Jonathan S. Berek. Lippencott, Williams and Wilkins. December 2011.

Abaid LN, Clarke-Pearson DL. Evaluation and Management of the Adnexal Mass. In: Gynecologic Cancer Management. Edited by Daniel Clarke-Pearson and John Soper. Lippencott, Wiley-Blackwell. 2010.

Abaid LN, Gehrig, PA. Management of Women at High Risk for Gynecologic Cancers. In: Gynecologic Cancer Management. Edited by Daniel Clarke-Pearson and John Soper. Lippencott, Wiley-Blackwell. 2010.

Abaid LN, Boggess JF. Current applications of laparoscopy in gynecologic oncology. In: Gynecologic Oncology. Edited by Paola A. Gehrig and Angeles A. Secord. Landes Bioscience. 2009.

Clarke-Pearson DL, Abaid LN. Thromboembolic Prevention. In: OB/GYN Requisites: Gynecologic Oncology. Edited by David Fishman. Saunders/Mosby-Elsevier. In press.

Abaid LN, Clarke-Pearson DL. Deep Vein Thrombosis and Pulmonary Embolism. In: The 5-Minute OB/GYN Clinical Consult. Edited by Paula J. Hilliard. Lippencott, Williams, and Wilkins. In press.

PRESENTATIONS
Poster Presentations:

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A phase IV, randomized study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting and activities of daily living in patients treated for gynecologic cancer. European Society of Gynaecological Oncology Annual Meeting; October 2015: Nice, FR.

MA, Mendivil AA, Abaid LN, Brown III JV, Micha JP, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy FollowingLaparoscopic Cytoreductive Surgery in the Treatment of Ovarian Carcinoma. International Gynecologic Cancer Society Annual Meeting; May 2015: Santiago, CL.

Rettenmaier MA, Abaid LN, Brown JV III, Micha JP, Lopez KL, Goldstein BH. A Comparison of Open Surgery, Robotic-Assisted Surgery and Conventional Laparoscopic Surgery in the Treatment of Morbidly Obese Endometrial Cancer Patients. ESJO Annual Meeting; October 2013: Liverpool, UK.

LN, Micha JP, Rettenmaier MA, Brown JV III, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Society of Gynecologic Oncology 42nd Annual Meeting, Austin TX, March 24-27, 2012.

Saig R, Abaid LN, Gehrig PA, Rutledge TL, Budwit D. Hormonal treatment of complex endometrial hyperplasia

and cancer. American College of Obstetricians and Gynecologists 57th Annual Clinical Meeting, Chicago, IL, May
2-6, 2009.

Milam MR, Abaid LN, Gehrig PA, Dos Reis R, Livasy C, Frumovitz M, Broaddus RR, Ramirez PT. Does microscopic nodal count predict nodal metastasis in early stage cervical cancer? A dual institution review. Society of Gynecologic Oncologists 39th Annual Meeting, Tampa, FL, March 9-12, 2008.

Abaid LN, Rutledge TL, Moore KN, Boggess JF, Van Le L, Fowler WC, Gehrig PA. Prognostic variables and
treatment outcomes in stage I leiomyosarcoma. Society of Gynecologic Oncologists 38th Annual Meeting, San Diego, CA, March 3-7, 2007.

Boggess JF, Gehrig PA, Bae-Jump VL, Abaid LN, Shafer A, Clarke-Pearson DL, Rutledge TL, Soper JT, Van Le L, Fowler WC. Robotic assistance improves minimally invasive surgery for endometrial cancer. Society of Gynecologic Oncologists 38th Annual Meeting, San Diego, CA, March 3-7, 2007.

Abaid LN, Wu JM, Boggess JF. Laparoscopic treatment of endometrial cancer: A cost-effectiveness analysis.
American Society of Clinical Oncology, Atlanta, GA, June 5, 2006.

Oral Presentations:
Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Society of Gynecologic Oncologists 39th Annual Meeting, Tampa, FL, March 9-12, 2008.

Abaid LN, Shafer A, Gehrig PA, Boggess JF. Fertility-sparing robotic radical trachelectomy: A case report.
Minimally Invasive Robotic Association 3rd Annual Meeting, Rome, Italy, January 24-26, 2008.

Shafer A, Abaid LN, Gehrig PA, Cantrell LA, Boggess JF. Robotic assisted laparoscopic cystectomy in pregnancy:
A case series. Minimally Invasive Robotic Association 3rd Annual Meeting, Rome, Italy, January 24-26, 2008.

Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the morbidly obese woman? Minimally Invasive Robotic Association 3rd Annual Meeting, Rome, Italy, January 24-26, 2008.

Moore KN, Moxley KM, Fader AN, Axtell AE, Rocconi RP, Abaid LN, Cass IA, Rose PG, Leath CA, Rutledge TL, Blankenship D, Gold MA. Serous Fallopian Tube Carcinoma: A Retrospective, Multi-institutional Case Control Comparison to Serous Adenocarcinoma of the Ovary. Society of Gynecologic Oncologists 38th Annual Meeting, San Diego, CA, March 3-7, 2007.

Shafer A, Gehrig P, Bae-Jump V, Abaid L, Clarke-Pearson D, Fowler W, Rutledge T, Soper J, Van Le L, Boggess J. Type III radical hysterectomy for obese women with cervical carcinoma: Robotic versus open. Society of Gynecologic Oncologists 38th Annual Meeting, San Diego, CA, March 3-7, 2007.

Abaid LN, Rutledge T. The role of radiotherapy in the treatment of uterine sarcoma: A twenty-five year
institutional  review. Mid Atlantic Gynecologic Oncology Society Meeting, Philadelphia, PA, October 7, 2006.

TEACHING EXPERIENCE
Teaching Activities:
2005 – 2008 University of North Carolina at Chapel Hill School of Medicine
Core lecture series on gynecologic oncology topics for 3rd year medical students during their ob/gyn clerkship

2004 – 2005 University of North Carolina at Chapel Hill School of Medicine Obstetrics and Gynecology Clerkship Tutorial Program Weekly mentoring session with third year medical students during their Ob/Gyn clerkship.

Grand Rounds:
Abaid LN. “Fertility-Sparing Options in the Treatment of Gynecologic and Non-Gynecologic Malignancies.”
University of North Carolina, Chapel Hill, NC, May 2007.

Abaid LN. “Updates in Cervical Dysplasia and HPV Management.” New Hanover Regional Medical Center,
Wilmington, NC, February 2007.

Abaid LN. “Should We or Shouldn’t We? A Brief Overview of Decision Analysis.” New Hanover Regional Medical Center, Wilmington, NC, April 2006.

Abaid LN. “Should We or Shouldn’t We? A Brief Overview of Decision Analysis.” University of North Carolina, Chapel Hill, NC, February 2006.

Abaid LN. “Management of Cervical Dysplasia.” University of North Carolina Student Health Service, Chapel Hill, NC, January 2006.

Abaid LN. “Prophylactic Oophorectomy: Indications in High-Risk and Low-Risk Patients.” WakeMed Hospital, Raleigh NC, November 2005.

Society Memberships:
2006 – present Fellow, American College of Obstetricians and Gynecologists
2005 – present Society of Gynecologic Oncologists, candidate member
2000 – present American College of Surgeons, junior fellow

Tiffany L. Beck, MD

Tiffany Beck, MD, MPH, FACOG attended Virginia Commonwealth University School of Medicine followed by a general OB/GYN residency at Magee Womens Hospital of University of Pittsburgh. She then completed her fellowship at University of Washington where she received training in complex robotic surgery, debulking procedures, delivery of chemotherapy/immunotherapy/biologic treatments, as well as the treatment of a broad spectrum of gynecologic cancers. Dr Beck is board-certified in Obstetrics and Gynecology and board-eligible in Gynecologic Oncology.

BUSINESS ADDRESS
Gynecologic Oncology Associates
351 Hospital Road
Suite 507
Newport Beach, CA  92663
Phone: (949) 642-1361

John V. Brown, MD

John V. Brown, MD, FACOG FACS attended Medical School at the University of Kansas. He completed an Internship and Residency in Gynecology and Obstetrics at the University of Washington. His fellowship in Gynecologic Oncology was obtained at the University of California, Los Angeles. He is a former Clinical Assistant Professor of Obstetrics and Gynecology at both the University of California, Los Angeles, and at the University of Southern California. He is a Fellow of the American College of Obstetrics and Gynecology and the American College of Surgeons.

CURRICULUM VITAE

John Vincent Brown III, M.D.

A. Business Address:


Gynecologic Oncology Associates
351 Hospital Road, Suite 507
Newport Beach, CA 92663
Phone: (949) 642-1361
Fax: (949) 642-1394

URL of Map


B. EDUCATION

Undergraduate:
University of Kansas
B.S., 1980
Major:  Organismal Biology
Cumulative GPA 3.93
Graduation with Distinction

Medical School:
University of Kansas School of Medicine
M.D., 1984
Position in Graduating Class, 24/144

Postgraduate:
University of California at Los Angeles

Training:
School of Medicine
Division of Gynecologic Oncology

Fellowship:  July 1, 1988 to June 30, 1990
University of Washington Medical School
Department of Obstetrics and Gynecology
Residency:  July 1, 1984 – June 30, 1988


C.  MEDICAL LICENSURE

Washington
California


D.  CERTIFICATION

American Association of Gynecologic Laparoscopy
Center of Excellence in Minimally Invasive Gynecologic Surgery
Surgeon Designee (2012)

Diplomat of the American Board of Obstetrics and Gynecology (1991)

Certificate of Special Qualification in Gynecologic Oncology  (1994)

Re-certified in Obstetrics and Gynecology and Gynecologic Oncology (1999)

 

E.  PROFESSIONAL BACKGROUND

Academic Appointments

Assistant Clinical Professor

University of California at Los Angeles

School of Medicine

Harbor/UCLA Medical Center

June 25, 1990 – 1999

Assistant Clinical Professor

University of Southern California

School of Medicine

October, 1999—2005

 

Professional Employment
Private Practice specializing in Gynecologic Oncology

Newport Beach, CA

1990-present

 

F.   AWARDS

Summerfield Scholar, 1977

Veta B. Lear Award, (4.0 GPA for Freshman year), 1977

Owl Society (Junior Men’s Honorary Society), 1979

Mortar Board, 1980

Omicron Delta Kappa (Vice President), 1980

Educational Foundation Scholarship, 1980

Phi Kappa Phi, 1980

J. George Moore Award (Best paper by a fellow, Western  Association Gynecologic Oncologists), 1990

 

G.    PROFESSIONAL SOCIETIES

American College of Obstetricians and Gynecologists (Fellow)

Society of Gynecologic Oncologists (Member)

American College of Surgeons (Fellow)

American Society of Clinical Oncologists (Member)

Western Association of Gynecologic Oncologists (Member)

Society of Surgical Oncologists (Member)

International Society of Gynecologic Cancer (Member)

Pacific Coast Obstetrical and Gynecological Society (Member)

 

H.    COMMITTEES/LEADERSHIP

Obstetrics and Gynecology Core Committee, Irvine Medical Center

Society of Gynecologic Oncology Education and Exhibit Ad Hoc Committee:

1997-1999.

Cancer Committee, Hoag Memorial Presbyterian Hospital:  2000-present.

Co-Director, Society of Gynecologic Oncologists Winter Meeting 1999-present

Co-Chair of Society of Gynecologic Oncology Clinical Practice Committee: 2004

Chair of Society of Gynecologic Oncology Clinical Practice Committee: 2005-2008.

Council Member of Society of Gynecologic Oncologists; 2005-2008

Member, Society of Gynecologic Oncology Clinical Practice Committee 2001- present

American College of Surgeons Committee on Applicants: 1998-present.

Member, Society of Gynecologic Oncologists Quality and Outcomes Committee 2010-present

Member, Society of Gynecologic Oncologists Annual Meeting Program Committee, 2010

Obstetrics and Gynecology Core Committee, Hoag Memorial Presbyterian Hospital:  2003-2009.

Gynecologic Cancer Foundation Nominating Committee, 2006

Member, Hoag Memorial Hospital Women’s Health Institute Advisory Council, 2010-

Member, Hoag Memorial Hospital Continuum of Care Task Force, 2010-

 

I.          PUBLICATIONS

Brown JV, Stenchever MA.  Cavernous lymphangioma of the vulva. Obstet Gynecol 1989;73:877-9.

Brown JV, Fu YS, Berek JS.  Ovarian metastases are rare in stage I adenocarcinoma of the cervix. Obstet Gynecol 1990;76:623-6.

Brown JV, Peters WA, Corwin DJ.  Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia. Gynecol Oncol 1991;40:25-28.

Brown JV, Karlan BY, Greenspoon JS, Rosove MH, Lagasse LD.  Perioperative coagulopathy in patients undergoing primary cytoreduction. Cancer 1993;71:2557-61

Malfetano J, Brown J, Abrams J, Homesley H, Benegno B, Braly P, Bean L, Malta E, Dziem G.  Filgrastim (r-met-HuG-CSF) as an Adjunct to Cyclophosphamide and Carboplatin Chemotherapy in Advanced Ovarian Carcinoma. Proc Am Soc Clin Oncol 1993;12:265.

Micha JP, Rettenmaier MA, Dillman R, Fraser P, Birk C, Brown JV.  Single dose Dexamethasone Taxol premedication.  Gynecol Oncol; 69:122-124, 1998.

Micha JP, Brown JV.  Primary surgical cure of stage III-B cervical carcinoma with adnexal metastasis.  Gynecol Oncol; 71, 317-319, 1998

Micha JP, Rettenmaier MA, Francis L, Willenberg R, Brown JV.  “Medically necessary” panniculectomy to facilitate radical pelvic surgery in morbidly obese patients. Gynecol Oncol; 69:237-242, 1998

Brown JV, Rettenmaier MA, Dillman R, Birk C, Culkin K, Micha JP.  Three hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer.  Gynecol Oncol; 68:166-168, 1998

Dillman RO, Nayak SK, Johnson D, Brown J, Chico S.  The potential to use short-term cultures of ovarian cancer cells as autologous tumor cell vaccines.  Proc Am Assoc Cancer Res 1997; 38:399, abstract 2676.

Dillman RO, Nayak SK, Brown JV, Mahdavi K, Beutel LD. The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer. Cancer Biother 1999;14:443-49.

Brown JV, Peters WA, Rettenmaier MA, Karlan BY, Dillman RA, Smith MR, Drescher CW, Micha JP. A phase I trial of a 3-day Topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum. Gynecol Oncol 79; 2000.

P Sabbatini, J Brown, Carol Aghajanian, M L Hensley, S Pezzulli, C O’Flaherty, M Lovegren, S Funt, M Warner, P Mitchell, M G Bolton, D Spriggs, B Duggan. A phase I/II study of PG-paclitaxel (CT-2103) in patients (pts) with recurrent ovarian, fallopian tube, or peritoneal cancer.  Proc Am Soc Clin Oncol 2002; abstract 871.

Brown JV, Peters WA, Rettenmaier MA, Dillman RA, Smith MR, Drescher CW, Micha JP. Three Consecutive Day Topotecan is an Active Regimen for Recurrent Epithelial Ovarian Cancer. Gynecol Oncol 2003;88:136-140.

Rettenmaier MA, Brown JV, Micha JP.  Modified vestibulectomy is inadequate treatment for secondary vulvar vestibulitis.  Jnl Gynecol Surg 2003;19(1):13-18.

Micha JP, Goldstein BH, Rettenmaier MA, Mattison J, Graham C, Birk CL, Brown JV.  Pilot Study of Outpatient Paclitaxel, Carboplatin and Gemcitabine for Advanced Stage Epithelial Ovarian, Peritoneal, and Fallopian Tube Epithelial Cancer. Gynecol Oncol 2004;94:719-724

Micha JP, Goldstein BH, Hunter JV, Rettenmaier MA, Brown, JV.  Long-term survival in an Ovarian Cancer Patient with Brain Metastases: A Case Report.  Gynecol Oncol 2004;92:978-980.

Brown JV, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP.  Laser ablation of surgical margins after excisional partial vulvectomy for VIN:  Effect on recurrence. J Repro Med  2005;50:345-350.

Rettenmaier MA, Goldstein BH, Brown JV, John CR, and Micha JP.  Impact of Gynecologic Oncologists on Referral Patterns and Care of Patients with Uterine Malignancies at a Community Hospital. Jnl Gynecol Surg 2004;20: 57-63.

Micha JP, Goldstein BH, Rettenmaier MA, Brown JV.  Cecal pelvic transposition following total pelvic exenteration.  Gynecol Oncol 2004;94:589-592.

Micha JP, Goldstein BH, Robinson PA, Rettenmaier MA, Brown JV.  Abdominal/Pelvic Coccidioidomycosis.  Gynecol Oncol 2005; 96; 256-258.

Micha JP, Goldstein BH, Mattison JA, Bader KM, Graham C, Rettenmaier MA, Brown JV, Markman M.  Experience with single agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer. Gynecol Oncol 2005;96:132-5.

Sabbatini P, Aghajanian C, Dizon D, Anderson S, Duport J, Brown JV, Peters WA, Jacobs A, Mehdi A, Rivkin S, Eisenfeld AJ, Spriggs D. Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.  J Clin Oncol 2004; 22: 4523.

Brown JV, Goldstein BH, Duma CM, Rettenmaier MA, Micha JP.Gamma-Knife

Radiosurgery for the Treatment of Ovarian Cancer Metastatic to the Brain.  Gynecol Oncol 2005; 97; 858-61.

Micha JP, Goldstein BH, Bock BV, Rettenmaier MA, Brown III JV. Spontaneous    Bacterial Peritonitis.   Int J Gynecol Cancer 2006; 16: 908-911.

Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV, John CR, Markman M. Surgery Alone or Surgery with a Combination Radiation or Chemo-Radiation for Management of Patients with Bulky Stage 1B2 Cervical Carcinoma. Intl J Gynecol Cancer 2006; 16: 1-5.

Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV. A Rare Caseof Coccygeal Endometriosis. Obstet Gynecol 2006; 107:1-2.

Rettenmaier MA, Goldstein BH, Brown III JV, Van Horn D, Micha JP.Recurrent gestational trophoblastic disease following persistently normal hCG titers: A rare occurrence. Accepted to the Am J Clin Oncol 2005.

Rettenmaier MA, Goldstein BH, Stallman JM, Brown III JV, Micha JP. GreatlyElevated Serum CA-125 Level in a Patient with a RupturedEndometrioma. J Gynecol Surg 2005; 21: 109-112.

Rettenmaier MA, Goldstein BH, Epstein HD, Brown JV 3rd, Micha JP.  Serous psammocarcinoma of the ovary: An unusual finding.  Gynecol Oncol  2005; 99:510-11.

Micha JP, Goldstein BH, Birk CL, Rettenmaier MA, Brown III JV.  Abraxane in the treatment of ovarian cancer:  The absence of hypersensitivity reactions.  Gynecol Oncol 2006; 100: 437-438.

Brown JV, Goldstein BH, Rettenmaier MA, Michelle MM, Graham CL, Micha JP. Laser Ablation of Surgical Margins After Excisional Partial Vulvectomy for VIN. Obstet Gynecol Surv 2005;60:584-5.

Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV. Pelvic RadiationNecrosis and Osteomyelitis Following Treatment for Advanced CervixCarcinoma. Gynecol Oncol 2006; 101: 349-352.

Rettenmaier MA, Goldstein BH, Stallman JM, Brown III JV Micha JP.Lymphoepithelial carcinoma of the cervix: Review and treatment course. J Gynecol Surg 2006; 21: 185-88.

Micha JP, Goldstein BH, Rettenmaier MA, Brown JV III, Markman M. Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma. Int J Gynecol Cancer 2006; 16: 1-5.

Micha JP, Goldstein BH, Epstein HD, Rettenmaier MA, Brown III JV. Ovarian Cancer Metastatic to the Breast.  Gynecol Oncol 2006;102: 386-390.

Rettenmaier MA, Goldstein BH, Stallman JM, Micha JP, Brown III JV.  Vaginal reconstruction following supra-levator exenteration.  Gynecol Oncol 2006; 102: 397-399.

Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV.  Neo-vagina Reconstruction Utilizing the Bladder and Urethra Following Radical Radiation Therapy.  J Gynecol Surg 2006;22:73-75.

Micha JP, Goldstein BH, Zusman D, Rettenmaier MA, Epstein HD Brown III JV. Malignant Pericardial Effusion Secondary to Ovarian Adenocarcinoma.  J Reprod Med 2007; 52: 971-3.

Rettenmaier MA, Goldstein BH, Haghighi B, Brown III JV, Micha JP. Serous endometrial intraepithelial carcinoma: Diagnosis and clinical management. J Gynecol Surg 2006;22: 69-72.

Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV. A response to Batt in A rare case of precoccygeal endometriosis. (Response to Letter to Editor). Obstets Gynecol 2006; 108:213-214.

Micha JP, Goldstein BH, Rettenmaier MA, Oglevie S, Lindsay SF, Haskell R, Brown JV III. Subclavian arterial puncture repair with Angio-Seal deployment. Gynecol  Oncol 2007; 104: 761-3.

Micha JP, Goldstein BH, Epstein HD, Rettenmaier MA, Doering R, Brown III JV.A Precarious Case of Multiple Enlarged Arteriovenous Malformations in the Uterus. J Gynecol Surg 2007; 23: 23-29.

Micha JP, Goldstein BH, Rettenmaier MA, Genesen M, Graham CL, Bader K,  Lopez KL, Nickle M, Brown JV. A Phase II Study of Outpatient First Line Paclitaxel, Carboplatin and Bevacizumab for Advanced Stage Epithelial Ovarian, Peritoneal, and  Fallopian Tube Cancer. Intl J Gynecol Cancer 2007;17: 771-6.

Brown JV, Goldstein BH, Lopez K, Rettenmaier MA, Graham CL, Micha JP.A Phase II, Multi-Center Trial of Weekly Topotecan In Patients With Recurrent Platinum Sensitive Epithelial Cancers of the Ovary, Fallopian Tube, and Peritoneum. Intl J Gynecol Cancer 2008; 18:249-54.

Micha JP, Goldstein BH, Brown JV, Birk C, Van Horn D, Rettenmaier MA. Tuberculosis Mimicking Cervical Carcinoma. Euro J Gynaecol Oncol 2007; 28: 316-318.

Micha JP, Goldstein BH, Rettenmaier MA, Tinnerman-Minailo E, Brown JV, McCllellan S, Bock BV. Recurrent Vulvar Lymphangitis Cured with Vulvectomy in a Cervical Carcinoma Patient.  J Reprod Med 2008; 53: 299-301.

Micha JP, Goldstein BH, Ellison D, , Brown JV, Rettenmaier MA. A Rare Case of Low-Grade Pelvic Masses with Spindle Cell and Fibroblastic Proliferation. J Med Case Reports 2007; 1: 16-19.

Micha JP, Goldstein BH, Brown JV, Clark M, Hu JC, Rettenmaier MA. Successful Management of Acute Renal Failure with Vaginal Pessary. A Case Report. Gynecol Surgery 2008; 5: 49-51.

Micha JP, Rettenmaier MA, Kistler M, Epstein HD, Lim J, Brown JV, Goldstein BH.     Retroperitoneal Schwannoma Presenting as a Gynecologic Mass: A Rare Case Report.  Gynecol Surg  2007; 23: 157-62.

Brown JV, Epstein HD, Kim R, Micha JP, Rettenmaier MA, Mattison J, Goldstein   Rapid Manifestation of CNS Metastatic disease in a Cervical Carcinoma Patient: A Case Report. Oncology 2007; 73: 273-276.

Micha JP, Brown JV, Sheffer EC, Chan K, Rettenmaier MA, Goldstein BH. Sarcoidosis Imitating Metastatic Cervical Cancer.  Arch Gynecol Obstets 2008;277:441-3.

Brown III JV, Micha JP, Asrat T, Epstein HD, Oglevie S, Rettenmaier MA, Goldstein BH.Contemporary Diagnosis and Management of a Uterine Arteriovenous Malformation: A  Case Report. Obstet Gynecol. 2008 Aug;112(2 Pt 2):467-70.

Rettenmaier MA, Brown III JV, Micha JP, Heinemann FS, Goldstein BH.Cerebral Nocardia Masquerading as Metastatic CNS Disease in an Endometrial Cancer     Patient. Accepted to Euro J Gynaecol Oncol 2008.

Micha JP, Goldstein BH, Rettenmaier MA, Brown JV, John CR, Markman M. The  Clinical Utility of CA-125 for Maintenance Therapy in the Treatment of Advanced Stage   Ovarian Carcinoma. Int J Gynecol Cancer. 2009 Mar-Apr;19(2):239-41.

Brown III JV, Epstein HD, Mattison JN, Micha JP, Rettenmaier MA, Goldstein BH. Occult  Fallopian Tube Cancer in a BRCA-1 Breast Cancer Patient: A Case Report. J Minim Invasive Gynecol 2008; 15:749-51.

Goldstein BH, Birk CL, Van Houten M, Veve R, Brown JV, Rettenmaier MA, Micha JP.Ovarian cancer and late onset paraneoplastic cerebellar degeneration:A Case Report. Arch Gynecol Obstet.  2009;280:99-101.

Chalas E, Brown JV, Cliby W. NSQIP—The new frontier?.  Gynecol Oncol 2008;111(2):163-5.

Micha JP, Graham CL, Rettenmaier MA, Brown JV 3rd, Goldstein BH.New perspectives in clinical research: the Women’s Cancer Research Foundation’sexperience. Perspect Health Inf Manag 2009;6:1-12.

Rettenmaier MA, Brown III JV, Micha JP, Heinemann FS, Goldstein BH.   Marlex Mesh Mimicking an Adnexal Malignancy. Hernia 2009; 13: 221-223.

Rettenmaier MA, Lopez K, Graham CL, Brown JV, John CR, Micha JP, Goldstein BH.  RealHand High Dexterity Instruments for the Treatment of Stage I Uterine Malignancy. JSLS 2009; 13:27-31.

Zekry N, Rettenmaier MA, Abaid LN, John CR, Micha JP, Brown JV, Goldstein BH.  Perivascular epithelioid cell neoplasms:  A systematic review of prognostic factors. Accepted for publication.  J Minim Invasive Gynecol 2009; 16:527-32.

Rettenmaier MA, Abaid LN, Hu JC, Brown JV, Micha JP, Goldstein BH. Delayed staple erosion into the bladder after removal of a benign ovarian mass.  J Minim Invasive Gynecol 2009; 16:491-492.

Rettenmaier MA, Zekry N, Chang M, Palmer A, Brown III JV, Micha JP, Goldstein BH.  A heavily pigmented vaginal perivascular epithelioid cell neoplasm.  J Obstet Gynecol 2009; 29: 676 -77.

Rettenmaier MA, Lopez K, Abaid LN, Brown III JV, Micha JP, Goldstein BH.  Borderline ovarian tumors and extended patient follow up:  An individual institution’s experience. J. Surg. Oncol. 2009;00:1–4.

Rettenmaier MA, Abaid LN, Erwin MR, John CR, Micha JP, Brown JV 3rd, Goldstein BH.  A retrospective Review of the GelPort System in Single-Port Access Pelvic Surgery.  J Minim Invasive Gynecol 2009; 16:743-7.

Rettenmaier MA, Lopez K, Abaid LN, Brown JV, Micha JP, Goldstein BH.Borderline Ovarian Tumors and Extended Patient Follow-up:An Individual Institution’s Experience. J Surg Oncol 2009; 101:18-21.

Rettenmaier MA, Abaid LN, Brown JV, Micha JP, Goldstein BH.  CHemotehrapy and patient co-morbidity in ventral site hernia development.  J Gynecol Oncol 2009;20:246-50.

Brown JV III, Epstein HD, Chang M, Goldstein BH. Sarcoidosis Presenting as an Intra-Peritoneal Mass.  Case Rep Oncol 2010;3:9-13.

Abaid LN, Lopez K, Micha JP, Rettenmaier MA, Brown JV, Goldstein BH.  Absence of bowel perforation and reasonable hypertension rates with bevacizumab in the treatment of advanced stage ovarian carcinoma. Eur J Gynaec Oncol 2010: Accepted for publication.

Brown JV III, Micha JP, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH.  A pilot study evaluating a novel regimen comprised of carboplatin, paclitaxel and bevacizumab for advanced stage ovarian carcinoma. Int J Gynecol Cancer 2010; 20: 1125-1131.

Abaid LN, Goldstein BH, Micha JP, Rettenmaier MA, Brown JV, Markman M.Improved Overall Survival with 12-Cycles of Single Agent Paclitaxel Maintenance Therapy Following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma.  Oncol 2010;78:389-393.

Rettenmaier CR, Rettenmaier NB, Wojciechowski T, Abaid LN, Brown III JV, Micha JP, Goldstein BH.  The Utility of Routine Follow-up Procedures in the Surveillance of Uterine Carcinoma: A 20-year   institutional review. Accepted to Oncol 2010.

Rettenmaier NB, Rettenmaier CR, , Wojciechowski T, Abaid LN, Brown III JV, Micha JP, Goldstein BH.  The Utility and Cost of Routine Follow-up Procedures in the Surveillance of Ovarian and Primary Peritoneal Carcinoma: A 16-year Institutional Review. Br J Cancer  2010;103L1657-62.

Abaid LN, Goldstein BH, Lopez KL, Micha JP, Brown JV, Rettenmaier MA, Markman M. The Prognostic Significance of Optimal Debulking in the Setting of a Complete Clinical Response for Advanced Ovarian Carcinoma Patients Receiving Maintenance Chemotherapy. Arch Gynecol Obstet 2011; 283: 1127-1131.

Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2012; 17:569-74.

Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.

Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer.  J Gynecol Oncol 2012; 23: 22-27.

Rettenmaier MA, Mendivil AA, Brown JV III, Abaid LN, Micha JP, Goldstein BH. Same Day Discharge in Clinical Stage 1 Endometrial Cancer Patients Treated with Total Laparoscopic Hysterectomy, Bilateral Salpingoophorectomy and Bilateral Pelvic Lymphadenectomy. Oncol 2012;82:321-326

Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV 3rd, Micha JP, Wabe MA, Goldstein BH. Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 2012; 17:569-74.

Abaid LN, Cupp JS, Brown JV, Goldstein BH. Primary Small Cell Neuroendocrine Carcinoma of the Endometrium. Oncol 2012; 5:439–443.

Brown JV III, Stallman JM, Wong H, Duma CM, Goldstein BH.   Spinal Epidural Metastasis in an Endometrial Cancer Patient.  Gynecol Oncol 2012; 2: 20-22.

Brown III JV, Mills MD, Wong H, Goldstein BH. Large Volume Cervical Varix Bleeding in a Gravid Patient. Gynecol Oncol 2013; 4: 20–22.

Mendivil AA, Micha JP, Brown JV 3rd, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH. Increased incidence of severe gastrointestinal events with first-line Paclitaxel, Carboplatin, and Vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. Int J Gynecol Cancer 2013;23:533-9.

Micha JP, Brown JV, Rettenmaier MA, Abaid LN, Mendivil AA, Lopez KI, Goldstein BH. Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian cancer. Clin Oncol 2013; Feb (letter).

Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother Pharmacol 2013;72:101-107.

Brown JV III, Heinemann FS, Laflamme LA, Goldstein BH. An Unusual Case Involving a Uterine Serous Carcinoma with an Intercurrent Lymphatic PEComa. Int J Clin Oncol 2012; 2: 157-160.

Abaid LN, Thomas RH, Epstein HD, Goldstein BH. Clostridial Abdominal Gas Gangrene Masquerading as a Bowel Perforation in an Advanced Stage Ovarian Cancer Patient. Infect 2013; 4: 885-888

Mendivil AA, Brown III JV, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. Robotic-Assisted Surgery for the Treatment of Pelvic Masses in Pregnant Patients: A Series of Four Cases and Literature Review.J Robot Surg 2013; 7: 333–337. Care 2013; 2: 124.

Rettenmaier CR, Rettenmaier NB, Abaid LN, Brown JV, Micha JP, Mendivil AA, Wojciechowski T, Goldstein BH, Markman M. The Incidence of Genitourinary and Gastrointestinal Complications in Open and Endoscopic Gynecologic Cancer Surgery. Oncology 2014; 86:303-307

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP, Goldstein BH. The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study. Int J Surg 2014; 12: 783-787.

Brown JV, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. The Safety and Feasibility of Robotic Lymph Node Staging in Early-Stage Ovarian Cancer. Int J Gynecol Cancer 24(8) 2014.

Brown JV, Rausei-Mills V, Crum CP, Goldstein BH. Management of a Female Adnexal Tumor of Probable Wolffian Origin Complicated by Intercurrent Disseminated Intravascular Coagulation. Clin Ovarian and Other Gyn Cancer. Dec 2013 58-61.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Hyperthermia 2015;31:8-14.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients. JSLS 2015;19: 1-5.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH.
The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma. Arch Gynecol Obstet 2015; 291:1381-6.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Lopez KL, Goldstein BH. Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. Int J Surg 2015; 19:27-30.

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A randomized, controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancer. Int J Gynecol Cancer. 2016; 26:389-393.

Brown JV 3rd, Epstein HD, Laflamme LA, Goldstein BH. First trimester placenta percreta with urinary bladder invasion. Int J Gynecol Obstet. 2016; 132:102-3.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience. Surg Oncol 2016; 25: 66-71.

 

J. PRESENTATIONS

Brown JV, Karlan BY, Lagasse LD.  Improved cytoreduction with the Ultrasonic Surgical Aspirator. Western Association of Gynecologic Oncologists. May, 1989.

Brown JV, Fu YS, Berek JS.  Ovarian metastases are rare in stage I adenocarcinoma of the cervix. Western Association of Gynecologic Oncologists. June, 1990.

Brown JV, Karlan BY, Rosove MH, Leuchter R, Futoran R, Lagasse LD.  Perioperative coagulopathy in patients undergoing primary cytoreduction. Western Association of Gynecologic Oncologists. June, 1991.

Brown JV, Rettenmaier MA, Micha JP. A pilot study of oral etoposide for recurrent or persistent ovarian cancer. Western Association of Gynecologic Oncologists. June, 1992.

Brown JV, Rettenmaier MA, Micha JP, Tullio R, Burke C. Taxol and Carboplatin is an effective outpatient regimen for advanced ovarian cancer. Western Association of Gynecologic Oncologists. June, 1995.

Dillman RO, Nayak SK, Johnson D, Brown J, and Chico S.  The potential to use short-term cultures of ovarian cancer  autologous tumor cell vaccines.  American Asssociation for Cancer Research. March, 1997.

Brown JV, Peters WA, Rettenmaier MA, Karlan BY, Dillman RA, Smith MR, Drescher CW, Micha JP. A phase I trial of a 3-day Topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum. Society of Gynecologic Oncologists. February, 2000.

Brown JV, Peters WA, Rettenmaier MA, Dillman RA, Smith MR, Drescher CW, Micha JP. Three Consecutive Day Topotecan is an Active Regimen for Recurrent Epithelial Ovarian Cancer.  Society of Gynecologic Oncologists. March, 2002.

P Sabbatini, J Brown, Carol Aghajanian, M L Hensley, S Pezzulli, C O’Flaherty, M Lovegren, S Funt, M Warner, P Mitchell, M G Bolton, D Spriggs, B Duggan. A phase I/II study of PG-paclitaxel (CT-2103) in patients (pts) with recurrent ovarian, fallopian tube, or peritoneal cancer.  American Society of Clinical Oncologists.  May, 2002.

Sabbatini P, Brown J, Bolton M.  Phase I/II study of PG-paclitaxel (CT 2103) in patients with recurrent ovarian cancer.  European Spring Oncology Conference. June, 2002.

Sabbatini P, Brown J, Peters WA, Andrew J, Mehdi A, Crozier MA, Rivkin S, Bolton MG. Phase I/II study of CT-2103 (Xyotax) in patients with recurrent ovarian cancer.  Memorial Sloan-Kettering Cancer Center, New York, NY; Gynecologic Oncology Associates, Newport Beach, CA; Pacific Gynecology Specialists; Virginia Mason Medical Center; Stockton Hematology Oncology Medical Group; Southwest Regional Cancer Cancer Center; Swedish Medical Center and Tumor Institute; Cell Therapeutics, Inc, Seattle, WA. European Organisation for Research and Treatment of Cancer (EORTC).  November, 2002.

Peters WA, Brown JV, Rivkin S, Bolton MG, Sabbatini P.  Phase I/II Study of CT-2103 (Xyotax) in Patients with Recurrent Ovarian Cancer.  Society of Gynecologic Oncologists.  February, 2003.

Brown JV, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP.  Laser ablation of surgical margins following excisional partial vulvectomy for vulvar intraepithelial neoplasia may decrease recurrences.  Pacific Coast Obstetrical and Gynecological Society.  September, 2003.

Micha, JP, Goldstein BH, Rettenmaier, MA, Mattison J, Graham CL, Birk CL,
and Brown JV. Pilot study of outpatient paclitaxel, carboplatin and
gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian
tube epithelial cancer. Eli Lilly Investigators Meeting March 2003, Phoenix, AZ.

Micha, JP, Goldstein BH, Rettenmaier, MA, Mattison J, Graham CL, Birk CL,and Brown JV. Paclitaxel, carboplatin and gemcitabine for treatment of advanced stage ovarian cancer. Eli Lilly Investigators Meeting April 2004, Phoenix, AZ.

Micha JP, Goldstein BH, Rettenmaier MA, Bader K, Graham C, Lopez K, Nickle M, Genesen M, Brown JV III.  Pilot Study of Outpatient Paclitaxel, Carboplatin and Bevacizumab for Advanced Stage Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer.  International Gynecologic Cancer Society Meeting, Santa Monica, CA; October 2006.

Abaid LN, Micha JP, Rettenmaier MA, Brown JV III, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Society of Gynecologic Oncology 42nd Annual Meeting, Austin TX, March 24-27, 2012.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV III, Micha JP, Lopez KL, Goldstein BH. A Comparison of Open Surgery, Robotic-Assisted Surgery and Conventional Laparoscopic Surgery in the Treatment of Morbidly Obese Endometrial Cancer Patients. ESJO Annual Meeting; October 2013: Liverpool, UK.

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A phase IV, randomized study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting and activities of daily living in patients treated for gynecologic cancer. European Society of Gynaecological Oncology Annual Meeting; October 2015: Nice, FR.

K.     RESEARCH GRANTS.

Bristol Myers Squibb
Principle Investigator
Phase I/II study of intravenous paclitaxel and carboplatin in patients with stage III/IV epithelial ovarian cancer (Three hour paclitaxel infusion)

Principle Investigator
Phase II study of intravenous paclitaxel and carboplatin in patients with stage III/IV epithelial ovarian cancer (One hour paclitaxel infusion)

Amgen
Co-Principle Investigator
Filgrastim (r-met-HuG-CSF) as an Adjunct to Cyclophosphamide and Carboplatin Chemotherapy in Advanced Ovarian Carcinoma

Smith Kline Beecham
Principle Investigator
A phase I/II trial of topotecan in patients with platinum and taxane refractory epithelial ovarian cancer

Principle Investigator
A phase II trial of three day topotecan q 21 days for recurrent epithelial carcinomas of the ovary, fallopian tube, and peritoneum.

Eli Lilly
Sub – Investigator
Phase II Trial of Intravenous Taxol, Carboplatin, and Gemzar in Patients With Stage III/IV Epithelial Ovarian Cancer, Stage III/IV Fallopian Tube Epithelial Cancer, Stage III/IV Endometrial Adenocarcinoma, Stage III/IV Malignant Primary Peritoneal Mesothelioma, and Stage III/IV Peritoneal Cancer

Eli Lilly
Principle Investigator
A Phase II Study of Gemcitabine and Carboplatin in Patients with Advanced, Persistent, or Recurrent Carcinoma of the Cervix

Ortho Biotech
Principle Investigator
A Phase II Trial of Doxil and Carboplatin for the Treatment of Advanced, Recurrent, or Persistent Endometrial Carcinoma

Cellpath
Sub – Investigator
A Phase II Trial of CP4071 (Digitoxin) In Patients With Recurrent Epithelial Mullerian Adenocarcinoma

Altarex
Sub – Investigator
A randomized, double-blind, placebo-controlled, phase IIB study of the safety and efficacy of OvaRex (MAb-B43.13) in ovarian cancer patients with an elevated serum CA-125 but without other evidence of disease

Altarex
Sub – Investigator
A multi-center clinical trial of intravenous OvaRex (MAb-B43.13) as post-chemotherapy consolidation for ovarian, tubal and peritoneal carcinoma

Atairgin Technologies, Inc.
Sub – Investigator
A clinical protocol to evaluate the role of lysophosphatidic acid as an aid in the differential diagnosis of ovarian cancer in women scheduled for surgery with a pelvic mass or a suspected ovarian malignancy

Atairgin Technologies, Inc.
Sub – Investigator
A protocol to characterize lysophosphatidic acid assay levels in women not suspected of ovarian cancer

Eli Lilly
Sub – Investigator
A Randomized Phase III Trial of Gemzar versus Doxil with Crossover Treatment Option for Patients with Platinum-Resistant Ovarian, Fallopian Tube, Peritoneal Cancer.

GlaxoSmithKline
Principle Investigator
A Phase II, Multi-Center Trial of Weekly Topotecan in Patients With Recurrent Platinum Sensitive Epithelial Cancers of the Ovary, Fallopian Tube, and Peritoneum

The ANA Study Group
Sub – Investigator
The ANC Study Group Registry: A Prospective Study of Neutropenic Complications

Online Collaborative Oncology Group (OCOG)
Sub – Investigator
A Randomized, Open-Label Study to Assess Time to Hemoglobin Response of a Front Load Dosing Regimen for Darbepoetin Alfa Compared to a Weekly Dose Regimen for Recombinant Human Erythropoietin in Patients with Non-Myeloid Malignancies Receiving Chemotherapy

Unither
Sub – Investigator
A Double Blind, Placebo-Controlled, Multicenter Clinical Trial Of Intravenous OvaRex Mab-B43.13 As Post-Chemotherapy Consolidation For Epithelial Carcinoma Of Ovarian, Tubal Or Peritoneal Origin

Cell Therapeutics
Site Principal Investigator
A phase I/II study of PG-paclitaxel (CT-2103) in patients (pts) with recurrent ovarian, fallopian tube, or peritoneal cancer

Telik
Sub – Investigator
Phase 3 Randomized Study of TLK286 versus Doxil/Caelyx or Hycamptin as Third-Line Therapy in Platinum Refractory or resistant Ovarian Cancer

Cell Therapeutics
Principle Investigator
CT-2103/Carboplatin for Patients with Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase II Study

Revised 11/14/10

Alberto A. Mendivil, MD

Alberto A. Mendivil, MD FACOG, FACS completed his undergraduate study in Animal Physiology and Neurosciences at the University of California, San Diego before receiving his medical degree at the University of Utah School of Medicine. Dr. Mendivil’s internship and residency training in Obstetrics and Gynecology was at the University of California, Irvine. His Fellowship training in Gynecologic Oncology was completed at the University of North Carolina, Chapel Hill.

Business Address
Gynecologic Oncology Associates
351 Hospital Road, Suite 507
Newport Beach, CA 92663
Ph. 949-642-1361
Fax 949-642-1394
amendivil@gynoncology.com

________________________________________________________________________

PERSONAL:

Foreign language: Spanish (speak, read, and write)

________________________________________________________________________

PROFESSIONAL TRAINING:

Fellowship

Gynecologic Oncology
Department of Obstetrics and Gynecology
University of North Carolina, Chapel Hill
CB# 7572
Chapel Hill, NC 27599-7572
PH: 919-966-5996
FAX: 919-843-5387
Fellowship Program Director: John F. Boggess, MD
July 1, 2007 to June 30, 2010

Internship/ Residency
Department of Obstetrics and Gynecology
University of California, Irvine Medical Center
101 The City Drive, Bldg 56, Suite 800
Orange, CA 92868
PH: 714-456-8224
Residency Program Director: Carol A. Major, MD
June 23, 2003 to June 22, 2007
_______________________________________________________________________

BOARD CERTIFICATION:

America Board of Obstetrics and Gynecology
General Obstetrics and Gynecology, 12/2009

American Board of Obstetrics and Gynecology
Gynecologic Oncology, 4/13

________________________________________________________________________

EDUCATION:

Medical School

University of Utah School of Medicine
Date of Graduation: May 24, 2003
-Degree: M.D.

Undergraduate

University of California, San Diego
Date of Graduation: June 14, 1998
-Degree: Bachelor of Science
-Major: Animal Physiology and Neurosciences
-Minor: Health Care/ Social Issues

________________________________________________________________________

PEER REVIEWED PUBLICATIONS:

Mendivil AA, Goldstein BH. Reply: Radical Hysterectomy and Survival Outcomes in the Management of Early Stage Cervical Cancer Surgical Oncology. Surg Oncol 2016; 25: 123.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience. Surg Oncol 2016; 25: 66-71.

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A randomized, controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancer. Int J Gynecol Cancer. 2016; 26:389-393.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Lopez KL, Goldstein BH. Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. Int J Surg 2015; 19:27-30.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH.
The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma
Arch Gynecol Obstet 2015; 291:1381-6.

Rettenmaier MA, Mendivil AA, Gray CM, Chapman AP, Stone MK, Tinnerman EJ, Goldstein BH. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia 2015; 24:1-7.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients. JSLS 2015;19: 1-5.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Hyperthermia 2015;31:8-14.

Brown JV, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. The Safety and Feasibility of Robotic Lymph Node Staging in Early-Stage Ovarian Cancer. Int J Gynecol Cancer 24(8) 2014.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP, Goldstein BH. The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study. Int J Surg 2014; 12: 783-787.

Mendivil AA, Micha JP, Stallman JM, Goldstein BH. A Very Rare Case of Vaginal Angiokeratoma. Euro J Gynaecol Oncol 2014; 3: 313-315.

Mendivil AA, Brown III JV, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. Robotic-Assisted Surgery for the Treatment of Pelvic Masses in Pregnant Patients: A Series of Four Cases and Literature Review.J Robot Surg 2013; 7: 333–337. Care 2013; 2: 124.

Mendivil AA, Cupp JS, Van Dalsem W, Caffarelli A, Goldstein BH. Multidisciplinary treatment of pelvic and cardiac intravenous leiomyosarcomatosis. Gynecol Oncol 2013; 6: 16–18.

LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother Pharmacol 2013;72:101-107.

Micha JP, Brown JV, Rettenmaier MA, Abaid LN, Mendivil AA, Lopez KI, Goldstein BH. Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian cancer. Clin Oncol 2013; Feb (letter).

Mendivil AA, Micha JP, Brown JV 3rd, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH. Increased incidence of severe gastrointestinal events with first-line Paclitaxel, Carboplatin, and Vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. Int J Gynecol Cancer 2013;23:533-9.

Mendivil AA, Stallman JM, Chad JN, Goldstein BH. An Unusual Case of Fallopian IntraepithelialTube Carcinoma with Mucinous Goblet Cell Differentiation. Gynecol Oncol 2012; 2: 47-50.

Micha JP, Mendivil AA, Cupp JS, Goldstein BH. Recurrent Lymphatic Ascites in a Patient Cured of CervicalCarcinoma. Gyn Oncol 2012; 2: 105-106.

Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV 3rd, Micha JP, Wabe MA, Goldstein BH. Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 2012; 17:569-74.

Rettenmaier MA, Mendivil AA, Brown JV III, Abaid LN, Micha JP, Goldstein BH. Same Day Discharge in Clinical Stage 1 Endometrial Cancer Patients Treated with Total Laparoscopic Hysterectomy, Bilateral Salpingoophorectomy and Bilateral Pelvic Lymphadenectomy. Oncol 2012;82:321-326

Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer.  J Gynecol Oncol 2012; 23: 22-27.

Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2012; 17:569-74.

Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.

Micha JP, Mendivil A, Epstein HD,  LaFlamme LA, Goldstein BH. An Unusual Case of Endometrioid Adenocarcinoma Arising from Endometriosis. 2011 J Repro Med, manuscript accepted for publication.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Mallory KM, Bae-Jump VL. AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. 2011 Repro Sci, manuscript accepted for publication.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival Outcomes for Women Undergoing Type III Robotic Radical Hysterectomy for Cervical Cancer: A 3-year experience. 2010 Gynecol Oncol, 117(2):260-5.

Cantrell LA, Zhou C, Mendivil A, Gehrig PA, Malloy KM, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy. 2009 Gyncol Oncol, 116(1): 92-98.

Boggess JF, Gehrig PA, Cantrell LA, Shafer A, Mendivil A, Rossi E, Hanna R. Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology. 2009 Obstet Gynecol, 114(3).

Mendivil A, Holloway RW, Boggess JF. Invited Review: Emergence of robotic assisted surgery in gynecologic oncology: American perspective. 2009 Gynecol Oncol, 114(2): S24-S31.

Mendivil A, Schuler KM, Gehrig PA. Invited Review: Non-Endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. 2009 Cancer Control, 16(1): 46-52.

Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? 2008 Gynecol Oncol, 111(1): 41-45.

Yessaian A, Mendivil A, Brewster WR. Population characteristics in cervical cancer trials: Search for external validity. 2005 Am J Obstet Gynecol, 192(2): 407-13.

La Cava A, Massa M, Mendivil A, Martini A, Albani S. Genetic Immunization Maps T Cell (Auto) Immune Responses to Self Antigens Homologous to Exogenous Proteins. 2002 Autoimmunity, 35(2): 105-10.

Prakken B, Wauben M, Genini D, Samodal R, Barnett J, Mendivil A, Leoni L, Albani S. Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’. 2000 Nature Medicine, 6(12): 1406-10.

BOOK CHAPTERS:

Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2011.

Mendivil A, Fowler WC. Early epithelial ovarian cancer. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Bae-Jump VL. Germ cell tumors. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Clarke-Pearson D. Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2009

________________________________________________________________________

ORAL PRESENTATIONS:

BRCA and the Hereditary Breast/ Ovarian Cancer Syndrome.  Grand Rounds presented at Nash Regional Medical Center, Rocky Mount, NC, April 14, 2009.

Gynecologic Surgery in the Obese Patient. Grand Rounds presented at the New Hanover Regional Medical Center, Wilmington, NC, March 6, 2009.

Robotic Surgery Training in Gynecologic Oncology: A Comparison of Fellow and Attending Surgical Times. Presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 5, 2009.

A Three-Year Analysis of Endometrial Cancer Staging via Robotic Assistance. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.

A Fellow and Attending Surgeon Comparison of Robotic Surgical Outcomes in A Fellowship Training Program. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.

Metformin’s Effects on Endometrial Cancer. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.

Growth of Robotic Surgery Among Gynecologic Oncologists. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.

Management of Primary Peritoneal and Fallopian Tube Carcinomas: Are they similar to Epithelial Ovarian Cancer?  25thAnnual Philip J. DiSaia Resident Paper Day.  UCI Department of Obstetrics and Gynecology. Orange, CA. May 12, 2007.

Absence of Cardiotoxicity with Long-Term Use of Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer.  24thAnnual Philip J. DiSaia Resident Paper Day.  UCI Department of Obstetrics and Gynecology. Costa Mesa, CA. May 19, 2006.

________________________________________________________________________

RESEARCH/ POSTER PRESENTATIONS:

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A phase IV, randomized study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting and activities of daily living in patients treated for gynecologic cancer. European Society of Gynaecological Oncology Annual Meeting; October 2015: Nice, FR.

MA, Mendivil AA, Abaid LN, Brown III JV, Micha JP, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy FollowingLaparoscopic Cytoreductive Surgery in the Treatment of Ovarian Carcinoma. International Gynecologic Cancer Society Annual Meeting; May 2015: Santiago, CL.

Rettenmaier MA, Abaid LN, Brown JV III, Micha JP, Lopez KL, Goldstein BH. A Comparison of Open Surgery, Robotic-Assisted Surgery and Conventional Laparoscopic Surgery in the Treatment of Morbidly Obese Endometrial Cancer Patients. ESJO Annual Meeting; October 2013: Liverpool, UK.

Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL,  Goldstein BH. A Phase II Study of Modified Dose-Dense Paclitaxel and Every 4 week Carboplatin for the Treatment of Advanced Stage Primary Epithelial Ovarian, Fallopian Tube, or PeritonealCarcinoma. March 2012 Society of Gynecologic Oncology Meeting, Austin, TX.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, and Bae-Jump VL: Rapamycin potentiates the effects of paclitaxel in uterine papillary serous carcinoma (UPSC) cells through inhibition of cell proliferation and induction of apoptosis. Abstract presented at the Annual meeting of the American Association for Cancer Research, Washington, DC, April 2010.

O’Malley DM, Achenbach S, Skaznik-Wikiel M, Nakayama JM, Mendivil A, Havrilesky LJ, Secord AA, DeBernardo R, Gehrig PA, Fader AN: Improved survival with chemotherapy and radiation in advanced-stage uterine clear cell carcinoma. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.

O’Malley DM, Nakayma J, Secord AA, DeBernardo R, Gehrig PA, Fader AN, Mendivil A, Cohn DE, Skaznik-Wikiel M, Havrilesky L: Benefit of Adjuvant Therapy in Early Stage Clear Cell Cancer of the Uterus? Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.

Mendivil A, Vogel TJ, Gehrig PA: A survival comparison between women with uterine serous and/or clear cell carcinoma with and without a history of breast cancer. Abstract presented at the Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, May 2009.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual Meeting of the American Association for Cancer Research, Denver, CO, April 2009.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual UNC Women’s Health Research Day Conference, Chapel Hill, NC, April 2009.

Mendivil A, Cantrell LA, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Endometrial Cancer: A Three-Year Experience. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Cantrell LA, Mendivil A, Zhou C, Gehrig PA, Bae-Jump VL: Metformin is a potent inhibitor of endometrial cancer cell proliferation- implications for a novel treatment strategy. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Cervical Cancer: A Three-Year Experience. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Hanna R, Cantrell LA, Gehrig PA, Mendivil A, Boggess JF: A cost analysis of robotic as compared to conventional laparoscopy for endometrial cancer staging. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Boggess JF, Shafer A, Cantrell LA, Abaid L, Mendivil A, Gehrig PA: Robotically Assisted Type III Radical Hysterectomy in a Morbidly Obese Woman. Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Mendivil A, Hunter MI, Han E, Tewari KS: Management Of Primary Peritoneal And Fallopian Tube Carcinomas In The Platinate-Taxane Era.  Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Gehrig PA, Cantrell LA, Shafer A,  Abaid L, Mendivil A, Boggess JF: What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?  Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Hunter MI, Ziogas A, Mendivil A, Brewster WR:  Second primary breast cancer after epithelial ovarian cancer and tumors of low malignant potential.  Abstract at the 39th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, CA, April 2005.

Mendivil A, Cole BC, Sawitzke A: Mapping B-cell epitopes on mycoplasma arthritidis mitogen (MAM) using lambda phage display peptide library.  Abstract at the Western Student Medical Research Forum, Deer Valley, UT, February 2001.

Prakken B, Samodal R, Mendivil A, Bonnin D, Lanza P, Amox D, Roord S, DeKleer I, Jones M, Carson D, Albani S.  An E. coli Heat Shock Protein dnaJ Peptide Homologous To The “Shared Epitope” Is A Trigger Of Pro-Inflammatory, TH-1 Type T Cell Responses In Patients With Early Rheumatoid Arthritis (RA).  Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.

Samodal R, Louie S, Amox D, Bonnin D, Yang X, Weaver B, Mendivil A, Prakken B, Carson D, Albani S. Immunomodulatory Effects Of Treatment With A “Shared Epitope” Peptide In Patients With Rheumatoid Arthritis. Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.

________________________________________________________________________
LEADERSHIP:

Administrative Chief Resident, UCI Medical Center, Dept. of OB/GYN, 2006-2007

ACOG Junior Fellow District IX, Section 7 Chair, 2005-2006

‘Life of Medicine’ undergraduate course co-instructor, UC Irvine, 2005

Student Body Co-President, University of Utah School of Medicine, 2002-2003

Student Advisory Committee, Department of Obstetrics and Gynecology, University of Utah School of Medicine, 2001

Association of Minority Medical Students, University of Utah School of Medicine Co-President, 1999-2000

National Medical Fellowships, Academy Fellow, University of Utah School of Medicine Representative, 2001-2002

2nd Year Class Co-President, University of Utah School of Medicine, 2000-2001

Executive Committee member, University of Utah School of Medicine, 2000-2001, 2002-2003

Alumni Association Board Member, University of Utah School of Medicine, 2000-2001, 2002-2003

Community Outreach Program Student Coordinator, University of Utah School of Medicine, 2000-2001

International Pharmacy Student Foundation Book Appeal Project, 2000

-Book drive organizing committee chairman (medical school section)

-Over 600 medical books were collected and donated to Cruz Roja Mexicana Hospital, Tijuana, Mexico

Medical Spanish Instructor- University of Utah School of Medicine, 1999-2001

________________________________________________________________________

AWARDS:

Best Fellow Presentation, Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, September, 2008

Philip J. DiSaia, MD UCI Medical Student Teaching Award, June 2007

UCI School of Medicine Resident Teaching Award, June 2007

UCI School of Medicine Resident Teaching Award, June 2005

UCI Dept. of OB/Gyn 2ND Year Resident Teaching Award, June 2005

UCI Dept. of OB/Gyn Teaching Resident of the Month, July 2004

UCI Dept. of Internal Medicine Outpatient Clinic Resident of the Month, July 2003

University of Utah School of Medicine Alumni Association Student Award, 2003

Bristol-Myers Squibb/ NMF Academic Medicine Research Fellowship, 2002

Linda Derrick Wood Scholarship, 2002

The Endocrine Society Research Fellowship, 2002

Herbert W. Nickens, M.D. Minority Medical Student Scholarship, 2001

National Medical Fellowships, Inc. Scholarship, 2001

Western Student Medical Research Award, 2001

Robert Wood Johnson Foundation Award, 2000-2001

Edward C. Klatt, M.D. Scholarship, 2000-2001

Bristol-Myers Squibb/ NMF Academic Medicine Fellowship (Finalist), 2000

Summer Institute for Medical Students, Betty Ford Center, Scholarship, 2000

National Medical Fellowships, Inc. Scholarship, 2000

Medical Student Research Fellowship, U of Utah School of Medicine, 2000

Dean A. Moffat, M.D. Memorial Scholarship, 1999-2000

Bernett Love Memorial Scholarship, 1999-2000

Undergraduate Research Scholar, University of California, San Diego, 1997

Howard Hughes Research Stipend, University of California, San Diego, 1997

Academic Grant, University of California, San Diego, 1993-1994

David Holmgren Memorial Scholarship, 1993

________________________________________________________________________

PROFESSIONAL ASSOCIATIONS:

American Association of Gynecologic Laparoscopy
Center of Excellence in Minimally Invasive Gynecologic Surgery
Surgeon Designee (2012)

Orange County California Medical Association, 2003-2007

Mid-Atlantic Gynecologic Oncology Society, 2008-present

Society of Gynecologic Oncologists, Fellow-in-training, 2007-present

American College of Surgeons, Resident-in-training, 2008-present

American College of Obstetricians and Gynecologists, Junior Fellow, 2004-present

National Hispanic Medical Association, 2000-2003

Kristina M. Mori, MD

Kristina Mori, MD, FACOG completed her undergraduate study at the University of California at Riverside. She attended Medical School at Tufts University School of Medicine and performed her residency at the Alpert Medical School of Brown University. Her Fellowship sub specialization in Gynecologic Oncology was completed at Northwestern University Feinberg School of Medicine.

BUSINESS ADDRESS
Gynecologic Oncology Associates
351 Hospital Road, Suite 507
Newport Beach, CA 92663
Ph. 949-642-1361
Fax 949-642-1394

EDUCATION AND TRAINING
2000-2004: University of California Riverside, Riverside, CA – Bachelor of Science in Biological Sciences with an emphasis in Medical Sciences
2004-2008: Tufts University School of Medicine, Boston, MA – Doctor of Medicine
2008-2012: Alpert Medical School of Brown University, Providence, RI – Residency in Obstetrics and Gynecology
2012-2015: Northwestern University Feinberg School of Medicine, Chicago, IL – Fellowship in Gynecologic Oncology

 

MEDICAL LICENSURE:
2015 – Current California Medical License
2012 – Current American Board of Obstetrics and Gynecology, Inc.: Active Candidate
2012 – Current Illinois Medical License
2008 – 2012 Rhode Island Limited Medical License

 

HONORS AND AWARDS
2012 American Association of Gynecologic Laparoscopists (AAGL) Special Resident in Minimally Invasive Surgery

2012 “Best 4th Year Teacher” voted by the PGY1-3 Ob/Gyn classes of Brown residents

2011 The Society of Laparoendoscopic Surgeons (SLS) Outstanding Laparoendoscopic Resident Surgeon

2011 “Best 3rd Year Teacher” voted by the PGY1- Ob/Gyn classes of Brown residents

2010 – 2011 Junior Fellow Chair District I Rhode Island Section, American Congress of Obstetricians and Gynecologists

2010 Resident Reporter, American Congress of Obstetricians and Gynecologist Annual Clinical Meeting, San Francisco, CA

2010 “Best 2nd Year Teacher” voted by the PGY1 Ob/Gyn class of Brown residents

2009 – 2010 Junior Fellow Vice Chair District I Rhode Island Section, American Congress of Obstetricians and Gynecologists

March 2009 Congressional Leadership Conference, American College of Obstetricians and Gynecologists, Washington, D.C.

2008 Harry H. Brenner M’33 Prize, Tufts University School of Medicine
An award given to a senior medical student who has shown the highest proficiency and interest in the field of obstetrics and gynecology

2005 – 2006 Selective Curriculum Representative, Tufts University School of Medicine

2002 – 2004 Dean Emerita Loda Mae Davis Scholarship, University of California Riverside

 

PUBLICATIONS:
Mori K, Neubauer N. Minimally Invasive Surgery in Gynecologic Oncology: A review. (ISRN Obstetrics and Gynecology, 2013 Aug 12;2013:312982. PMID: 23997959)

Mori K, Lurain JR. Human Chorionic Gonadotropin. In UpToDate, Falk SJ (Ed), UpToDate, Waltham, MA, 2013.

PRESENTATIONS:
Mori K, Hachey K, Kent J, Tejada-Berges T. Decision-Making Among Hispanic BRCA Positive Women Considering Prophylactic Surgery. Oral Presentation, New England Association of Gynecologic Oncologists Annual Meeting, June 2011, Stowe, Vt

Korbly NB, Kassis NC, Mori K, Lopes VV, Hampton BS, Sung VW. Effect of Concomitant Anterior Repair on Tension-Free Sling Outcomes. Poster Presentation, Society of Gynecologic Surgeons Annual Scientific Meeting, March 2012, Baltimore, MD

Mori K, Akers SN, Bshara W, Buttin B, Frederick P, Helenowski I, Morrison CD, Odunsi K, Schink J, Scholtens D, Wei JJ, Kim JJ. Gamma-Synuclein Expression in Ovarian Cancer. Poster Presentation, American Society of Clinical Oncology Annual Meeting, June 2013, Chicago, IL

Mori K, Akers SN, Bshara W, Buttin B, Frederick P, Helenowski I, Morrison CD, Odunsi K, Schink J, Scholtens D, Wei JJ, Kim JJ. Gamma synuclein expression in the primary tumor and metastases of ovarian cancer. Poster Presentation, Western Association of Gynecologic Oncologists Annual Meeting, June 2013, Seattle, WA

Mori K. Case presentation on high-risk gestational trophoblastic neoplasia. International Society for the Study of Trophoblastic Diseases World Congress, Sept 2013, Chicago, IL

Mori K, Hoppenot C, Helenowski I, Neubauer N. The use of minimally invasive surgery in ovarian cancer after neoadjuvant chemotherapy. Society of Gynecologic Oncology Annual Meeting, March 2015, Chicago, IL

 

PROFESSIONAL ASSOCIATIONS:
American Congress of Obstetricians and Gynecologists (2007 – Present)
American Society of Clinical Oncology (2012 – Present)
Society of Gynecologic Oncology (2012 – Present)